Condition: Ascites · Paracentesis · Cirrhosis · Sponsor: University Hospital, Grenoble
The hypothesis is that the Alfapump® strategy would be more effective in terms of QALYs generated , and that the cost of Alfapump® device and its implantation will be totally or partially offset by the reduction in the number of evacuating parentheses performed and the reduction in the number of complications in patients with refractory ascites awaiting liver transplantation or not. On the other hand, given the difference in the clinical profiles of these two populations (whether or not they are awaiting transplantation), these two populations will be study separately Evaluation of the medical-economic impact at 1 year of the two therapeutic strategies: implantation of Alfapump® versus repeated evacuating paracentesis in cirrhotic patients with refractory ascites without scheduled liver transplantation.
This description comes directly from the study's public registry record.
Sandra DAVID-TCHOUDA, MD · +33 476 76 71 86 · sdavidtchouda@chu-grenoble.fr
Sandrine MASSICOT · +33 476 76 88 60 · smassicot@chu-grenoble.fr
Always discuss trial participation with your own doctor first.
| Amiens-Picardie University Hospital | Amiens, France | Recruiting |
| Chu Angers | Angers, France | Recruiting |
| Jean MINJOZ Univesity Hospital | Besançon, France | Recruiting |
| Haut-Lévêque Hospital | Bordeaux, France | Not Yet Recruiting |
| Beaujon Hospital | Clichy, France | Recruiting |
| Grenoble University Hospital | Grenoble, France | Recruiting |
| LA PITIE SALPETRIERE Univesity Hospital | Paris, France | Recruiting |
| Chu Poitiers | Poitiers, France | Not Yet Recruiting |
| Chu Pontchaillou | Rennes, France | Recruiting |
| Toulouse University Hospital | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03506893